Mrs Sandra Lea Simon, MSPA,CCC-SLP | |
5200 Turkington Rd, Acme, WA 98220 | |
(360) 383-2012 | |
Not Available |
Full Name | Mrs Sandra Lea Simon |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 5200 Turkington Rd, Acme, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376897272 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | LL60312910 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sandra Lea Simon, MSPA,CCC-SLP 1820 Samish Ln, Bellingham, WA 98229-9321 Ph: (360) 676-0165 | Mrs Sandra Lea Simon, MSPA,CCC-SLP 5200 Turkington Rd, Acme, WA 98220 Ph: (360) 383-2012 |
News Archive
Now that senators Patty Murray of Washington and Hillary Clinton of New York, have dropped their objections to acting FDA Commissioner Lester Crawford becoming the permanent commissioner, approval for the sale of the Plan B "morning-after" contraceptive without a prescription should be granted with the minimum of delay.
The time for ethical reflection is before experimentation begins, especially in the case of potential new methods for creating human embryos for research, according to bioethicists from Wake Forest University Baptist Medical Center and the Mayo Clinic in the spring issue of Ethics & Medicine.
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.
New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure-suggesting the approach holds promise for treating accidental infections in laboratory or hospital settings.
› Verified 5 days ago